Blinded Placebo Oral Suspension for Diabetes Trial from Germany
This is a liquid placebo suspension in measured doses, identical in taste and appearance to the active drug, used in double-blinded Phase III clinical trials for diabetes medications. It falls under HTS 3006.93.60.00 as a blinded clinical trial kit in liquid form for oral intake, per Chapter 30 Note 6(e), excluding actual medicaments.
Duty Rate — Germany → United States
Rate breakdown
Import Tips
• Obtain FDA approval via Investigational New Drug (IND) application confirming recognized clinical trial status to justify 3006 classification
• Provide sponsor documentation showing product is a placebo or blinded kit in measured doses for oral intake, avoiding misclassification as food under Chapter 21
• Label clearly as 'Clinical Trial Material - Not for Sale' with stability data to prevent customs holds on shelf-life concerns